Within the biotech space, Veralto Corporation (VLTO) has reported a significant institutional ownership of 96%. Geode Capital Management LLC and Jefferies are among the latest firms to increase their investments in VLTO. Veralto's acquisition of TraceGains opened a window of projected robust growth, despite potential profitability challenges. The company also invested in Axine Water Technologies, signaling a major clean tech partnership. Quarterly dividends have been announced, with reports of strong Q3 growth and escalated EPS guidance. However, there were concerns regarding the company's capital allocation trends and recent insider selling. Despite this, there's discussion of superior growth catalysts in Veralto's operating segments, although there are suggestions its share price growth may not be fully backed by fundamentals. Statements from CEO Jennifer Honeycutt and senior VP Surekha Trivedi have also been noted alongside new board member, Vijay Sankaran. On the investment front, Janus Henderson Group PLC, Zurcher Kantonalbank, and Point72 Hong Kong Ltd have increased their holdings in VLTO, while Fisher Asset Management LLC reported selling its shares.
Veralto Corporation VLTO News Analytics from Wed, 13 Sep 2023 23:22:37 GMT to Sat, 14 Dec 2024 01:50:22 GMT - Rating 6 - Innovation 5 - Information 9 - Rumor 3
